Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Report suggests declines in global fertility rates set to transform global population pattern by 2100
- WHO says nearly 7000 avoidable deaths reported in Europe due to COVID-19 pandemic
- New study shows intermittent fasting may increase chances of death due to cardiovascular disease
- WHO study shows USD 39 return for each dollar invested in fight against TB
- Pakistan registers first polio case of 2024